VeraBank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $690K | Sell |
28,634
-3,894
| -12% | -$102K | 0.11% | 93 |
|
|
2026
Q1 | $913K | Sell |
32,528
-7,399
| -19% | -$197K | 0.17% | 82 |
|
|
2025
Q4 | $994K | Sell |
39,927
-355
| -0.9% | -$8.95K | 0.18% | 79 |
|
|
2025
Q3 | $1.03M | Sell |
40,282
-286
| -0.7% | -$7.06K | 0.19% | 78 |
|
|
2025
Q2 | $983K | Buy |
40,568
+8,625
| +27% | +$201K | 0.2% | 80 |
|
|
2025
Q1 | $809K | Hold |
31,943
| – | – | 0.23% | 73 |
|
|
2024
Q4 | $847K | Sell |
31,943
-3,105
| -9% | -$84.2K | 0.24% | 73 |
|
|
2024
Q3 | $1.01M | Sell |
35,048
-1,675
| -5% | -$48.9K | 0.3% | 65 |
|
|
2024
Q2 | $1.03M | Sell |
36,723
-1,300
| -3% | -$35.8K | 0.32% | 58 |
|
|
2024
Q1 | $1.06M | Sell |
38,023
-684
| -2% | -$19K | 0.33% | 60 |
|
|
2023
Q4 | $1.11M | Sell |
38,707
-2,445
| -6% | -$73.9K | 0.38% | 55 |
|
|
2023
Q3 | $1.37M | Buy |
41,152
+459
| +1% | +$16.2K | 0.52% | 47 |
|
|
2023
Q2 | $1.49M | Sell |
40,693
-5,746
| -12% | -$224K | 0.58% | 45 |
|
|
2023
Q1 | $1.89M | Hold |
46,439
| – | – | 0.88% | 30 |
|
|
2022
Q4 | $2.38M | Sell |
46,439
-1
| -0% | -$48 | 1.19% | 21 |
|
|
2022
Q3 | $2.03M | Hold |
46,440
| – | – | 1.28% | 20 |
|
|
2022
Q2 | $2.44M | Buy |
46,440
+2,330
| +5% | +$119K | 1.43% | 18 |
|
|
2022
Q1 | $2.28M | Sell |
44,110
-791
| -2% | -$41K | 1.18% | 23 |
|
|
2021
Q4 | $2.65M | Hold |
44,901
| – | – | 1.34% | 22 |
|
|
2021
Q3 | $1.93M | Buy |
44,901
+29
| +0.1% | +$1.28K | 1.09% | 27 |
|
|
2021
Q2 | $1.76M | Buy |
44,872
+1,350
| +3% | +$52.5K | 1.05% | 30 |
|
|
2021
Q1 | $1.58M | Buy |
43,522
+1,043
| +2% | +$37K | 1.02% | 30 |
|
|
2020
Q4 | $1.56M | Sell |
42,479
-2,226
| -5% | -$81.7K | 1.1% | 28 |
|
|
2020
Q3 | $1.56M | Sell |
44,705
-132
| -0.3% | -$4.63K | 1.19% | 25 |
|
|
2020
Q2 | $1.39M | Buy |
44,837
+991
| +2% | +$33.7K | 1.14% | 27 |
|
|
2020
Q1 | $1.36M | Sell |
43,846
-159
| -0.4% | -$5.42K | 1.32% | 23 |
|
|
2019
Q4 | $1.64M | Hold |
44,005
| – | – | 1.32% | 23 |
|
|
2019
Q3 | $1.5M | Sell |
44,005
-1,159
| -3% | -$42.1K | 1.35% | 23 |
|
|
2019
Q2 | $1.86M | Sell |
45,164
-687
| -1% | -$27.3K | 1.74% | 13 |
|
|
2019
Q1 | $1.85M | Sell |
45,851
-527
| -1% | -$21.1K | 1.76% | 14 |
|
|
2018
Q4 | $1.92M | Buy |
+46,378
| New | +$1.93M | 2.07% | 11 |
|
Other funds holding PFE
VeraBank's PFE Position: Q2 2026 in Review
VeraBank reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $102K and leaving 28,634 shares worth $690K. The position accounts for 0.11% of the portfolio, ranked #93.
VeraBank first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.65M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- VeraBank held 28,634 shares of Pfizer worth $690K as of Q2 2026.
- VeraBank sold 3,894 Pfizer shares in Q2 2026, an estimated $102K.
- Pfizer made up 0.11% of VeraBank's portfolio in Q2 2026, its #93 holding.
- VeraBank first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- VeraBank's Pfizer position peaked at $2.65M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.